Overview

A 21 Day Irritation Study in Healthy Volunteers With Diacerein 1% Ointment

Status:
Completed

Trial end date:
2018-01-30

Target enrollment:

Participant gender:

Summary

Single center, randomized, controlled, evaluator blinded, within-subject study to evaluate the irritation potential of diacerein1% ointment on normal skin of healthy volunteers, using a cumulative irritancy patch test (CIPT) procedure.

Phase:

Phase 1

Details

Lead Sponsor:

Castle Creek Pharmaceuticals, LLC

Collaborator:

TKL Research, Inc.

Treatments:

Diacetylrhein